Neurocrine Biosciences
NBIX
#1482
Rank
A$17.92 B
Marketcap
$177.51
Share price
-1.75%
Change (1 day)
-0.38%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Net assets

Net assets on the balance sheet as of June 2024 : A$3.76 B

According to Neurocrine Biosciences 's latest financial reports the company has A$3.76 B in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Neurocrine Biosciences - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$A$3.27 B30.54%
2022-12-31$A$2.50 B32.81%
2021-12-31$A$1.88 B29.29%
2020-12-31$A$1.46 B61.31%
2019-12-31$A$0.90 B32.81%
2018-12-31$A$0.68 B43.12%
2017-12-31$A$0.47 B9.12%
2016-12-31$A$0.43 B-25.04%
2015-12-31$A$0.58 B128.96%
2014-12-31$A$0.25 B88.53%
2013-12-31$A$0.13 B-9.33%
2012-12-31$A$0.14 B154.1%
2011-12-31$A$58.59 M206.66%
2010-12-31$A$19.1 M332.2%
2009-12-31$A$4.42 M-91.7%
2008-12-31$A$53.24 M-60.8%
2007-12-31$A$0.13 B-65.97%
2006-12-31$A$0.39 B-25.12%
2005-12-31$A$0.53 B4.76%
2004-12-31$A$0.50 B-3.28%
2003-12-31$A$0.52 B32.2%
2002-12-31$A$0.39 B-34.55%
2001-12-31$A$0.60 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
A$2.97 B-20.84%๐Ÿ‡บ๐Ÿ‡ธ USA
A$14.62 B 288.64%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$2.36 M-99.94%๐Ÿ‡บ๐Ÿ‡ธ USA
A$20.45 B 443.42%๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.23 B 171.84%๐Ÿ‡บ๐Ÿ‡ธ USA
A$131.95 B 3,406.10%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.72 B-80.85%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$54.59 M-101.45%๐Ÿ‡บ๐Ÿ‡ธ USA